Advertisement

Topics

Alzeca Biosciences Closes $11 Million Series A Financing

08:30 EDT 17 Aug 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Funds will advance development of first targeted imaging agent on conventional MRI to detect beta-amyloid plaques of early Alzheimer’s disease Alzeca Biosciences, Inc., an early-stage healthcare diagnostic company f...

Other Sources for this Article

Alzeca Biosciences, Inc.
Carlo Medici, 1-609-933-1258
CEO
carlo@alzeca.com
or
For Media
Bioscribe
Joan Kureczka, 1-415-821-2413
Joan@bioscribe.com

NEXT ARTICLE

More From BioPortfolio on "Alzeca Biosciences Closes $11 Million Series A Financing"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Radiology
Radiology is the branch of medicine that studies imaging of the body; X-ray (basic, angiography, barium swallows), ultrasound, MRI, CT and PET. These imaging techniques can be used to diagnose, but also to treat a range of conditions, by allowing visuali...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...